共享决策在慢性肾脏病患者血管通路全生命周期管理中的应用进展

叶雪萍; 俞伟萍; 钱雨萌

doi:10.3969/j.issn.1671-4091.2026.05.010

中国血液净化 ›› 2026, Vol. 25 ›› Issue (05) : 411-414. DOI: 10.3969/j.issn.1671-4091.2026.05.010

综述

共享决策在慢性肾脏病患者血管通路全生命周期管理中的应用进展

叶雪萍俞伟萍钱雨萌

作者信息 +

Research progress in shared decision-making through entire life cycle management of vascular access in patients with chronic kidney disease

YE Xue-ping, YU Wei-ping, QIAN Yu-meng

Author information +

文章历史 +

摘要

血管通路的管理是维持血液透析治疗的核心环节，其合理选择与长期维护直接影响患者的生存质量。血管通路的全生命周期管理涵盖规划、建立、使用至移除的全过程，该过程涉及多方面的临床权衡，需综合循证依据、患者意愿与医疗资源等多重因素。共享决策(shared decision making，SDM)作为一种以患者为中心、强调医患共同参与的医疗决策模式，在血管通路管理中具有重要价值。本文对共享决策在慢性肾脏病患者血管通路全生命周期管理中的应用现状进行系统阐述，分析当前实践中的关键挑战，并提出有针对性的推广策略，旨在为构建科学、系统的血管通路决策体系提供理论参考与实践指引。

Abstract

Management of vascular access is a key step in maintaining hemodialysis efficacy. Appropriate selection and long-term maintenance of vascular access directly impact on quality of life of the patients. The lifelong management of vascular access encompasses the entire process from planning and establishment to utilization and removal, which involves multifactorial clinical evaluations and requires integration of evidence-based guidelines, patient preference, and healthcare resources. Shared decision-making is a patient-centered model emphasizing joint participation of physician and patient in treatment decisions, and is a valuable method of vascular access management. This paper systematically reviews current application of shared decision-making in lifelong management of vascular access, analyzes key challenges in clinical practice, and proposes targeted promotion strategies, aiming to provide theoretical references and practical guidelines for establishing a scientific and systematic decision-making framework for vascular access in patients with chronic kidney disease.

导出引用

叶雪萍俞伟萍钱雨萌. 共享决策在慢性肾脏病患者血管通路全生命周期管理中的应用进展[J]. 中国血液净化. 2026, 25(05): 411-414 https://doi.org/10.3969/j.issn.1671-4091.2026.05.010

YE Xue-ping, YU Wei-ping, QIAN Yu-meng. Research progress in shared decision-making through entire life cycle management of vascular access in patients with chronic kidney disease[J]. Chinese Journal of Blood Purification. 2026, 25(05): 411-414 https://doi.org/10.3969/j.issn.1671-4091.2026.05.010

中图分类号： R692

参考文献

[1] 项目组中国腹膜透析管理现状白皮书. 中国腹膜透析管理现状白皮书[J]. 中华肾脏病杂志, 2022,38(12): 1076-1104.
[2] OSOFSKY R, BYRD D, REAGOR J, et al. Initial Outcomes Following Introduction of Percutaneous Arteriovenous Fistula Program with Comparison to Historical Surgically Created Fistulas[J]. Ann Vasc Surg, 2021,74: 271-280.
[3] 中华医学会肾脏病学分会. 中国肾脏病数据登记系统2024年度报告[R]. 天津: 2025.
[4] VEATCH R M. Models for ethical medicine in a revolutionary age. What physician-patient roles foster the most ethical realtionship?[J]. Hastings Cent Rep, 1972,2(3): 5-7.
[5] WOHLGEMUTH C, PENMAN K, DESAI M, et al. Reaching a shared understanding of shared decision making in health care: NICE's experience of scoping the shared decision making guideline[J]. J Eval Clin Pract, 2019,25(6): 1027-1029.
[6] 朱懿珍, 张爽, 关玉珠, 等. 共享决策在ICU中的应用进展[J]. 中华护理杂志, 2021,56(2): 289-294.
[7] 王贝贝, 董柏君, 杨艳. 共享决策在局限性前列腺癌病人治疗决策中的应用进展[J]. 护理研究, 2021,35(7): 1212-1216.
[8] 唐涵, 崔盼盼, 董诗奇, 等. 家庭参与癌症病人治疗决策的研究进展[J]. 护理研究, 2020,34(15): 2705-2708.
[9] 曹洁, 孙彩红, 丁艳, 等. 前列腺癌病人手术决策类型及其影响因素[J]. 护理研究, 2020,34(11): 1878-1881.
[10] 曹琴琴, 张宗侠, 王西鸽, 等. 共享决策在急诊心血管疾病护理中的应用进展[J]. 中华护理杂志, 2019,54(4): 595-598.
[11] 高雅靖, 单岩, 周越, 等. 老年晚期慢性肾脏病患者共享决策的研究进展[J]. 中国护理管理, 2020,20(9): 1409-1412.
[12] 王雯雯, 曹艳佩, 黄晓敏, 等. 慢性肾脏病病人透析治疗决策困境现状及影响因素[J]. 护理研究, 2020,34(23): 4129-4134.
[13] 金其庄, 王玉柱, 叶朝阳, 等. 中国血液透析用血管通路专家共识(第2版)[J]. 中国血液净化, 2019,18(06): 365-381.
[14] LOK C E, HUBER T S, LEE T, et al. KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update[J]. Am J Kidney Dis, 2020,75(4 Suppl 2): S1-S164.
[15] MUREA M, GEARY R L, HOUSTON D K, et al. A randomized pilot study to evaluate graft versus fistula vascular access strategy in older patients with advanced kidney disease: results of a feasibility study[J]. Pilot Feasibility Stud, 2020,6: 86.
[16] WOO K, PIETERS H. The patient experience of hemodialysis vascular access decision-making[J]. J Vasc Access, 2021,22(6): 911-919.
[17] 冯珍珍, 赵慧杰, 寇洁, 等. 血液透析患者参与血管通路共享决策类型及影响因素研究[J]. 中国血液净化, 2022,21(01): 66-70.
[18] van der VEER S N, HALLER M C, PITTENS C A C M, et al. Setting Priorities for Optimizing Vascular Access Decision Making--An International Survey of Patients and Clinicians[J]. PLoS One, 2015,10(7): e128228.
[19] HUBER T S, BERCELI S A, SCALI S T, et al. Arteriovenous Fistula Maturation, Functional Patency, and Intervention Rates[J]. JAMA Surg, 2021,156(12): 1111-1118.
[20] 中华医学会肾脏病学分会专家组. 透析通路中国指南（2024年版）[J]. 中华肾脏病杂志, 2024,40(12): 990-1070.
[21] XI W, MACNAB J, LOK C E, et al. Who should be referred for a fistula? A survey of nephrologists[J]. Nephrol Dial Transplant, 2010,25(8): 2644-2651.
[22] ELLIOTT M J, RAVANI P, QUINN R R, et al. Patient and Clinician Perspectives on Shared Decision Making in Vascular Access Selection: A Qualitative Study[J]. Am J Kidney Dis, 2023,81(1): 48-58.
[23] QIAN J, LEE T, THAMER M, et al. Racial Disparities in the Arteriovenous Fistula Care Continuum in Hemodialysis Patients[J]. Clin J Am Soc Nephrol, 2020,15(12): 1796-1803.
[24] 高希娟, 徐晨艳, 付敬, 等. 血液透析病人血管通路决策过程的质性研究[J]. 循证护理, 2024,10(03): 561-564.
[25] GRUBBS V, JAAR B G, CAVANAUGH K L, et al. Impact of pre-dialysis nephrology care engagement and decision-making on provider and patient action toward permanent vascular access[J]. BMC Nephrol, 2021,22(1): 60.
[26] XI W, HARWOOD L, DIAMANT M J, et al. Patient attitudes towards the arteriovenous fistula: a qualitative study on vascular access decision making[J]. Nephrol Dial Transplant, 2011,26(10): 3302-3308.
[27] LOK C E, HUBER T S, LEE T, et al. KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update[J]. Am J Kidney Dis, 2020,75(4 Suppl 2): S1-S164.
[28] 赵雅兴, 李霞, 阎虹. 基于网络的患者决策辅助在肿瘤患者临床决策中的应用进展[J]. 护理学杂志, 2024,39(10): 121-125.
[29] ALLON M. Vascular Access for Hemodialysis Patients: New Data Should Guide Decision Making[J]. Clin J Am Soc Nephrol, 2019,14(6): 954-961.
[30] JIANG Y, GUO J, CHEN M, et al. Development of a Pulmonary Rehabilitation Patient Decision Aid for Patients with Chronic Obstructive Pulmonary Disease: Mixed Methods Study[J]. Int J Chron Obstruct Pulmon Dis, 2023,18: 1377-1389.
[31] LEDERER S, FISCHER M J, GORDON H S, et al. A question sheet for adult patients with chronic kidney disease[J]. BMC Nephrol, 2016,17(1): 155.
[32] DOROUGH A, NARENDRA J H, WILKIE C, et al. Stakeholder-Guided Development of Dialysis Vascular Access Education Materials[J]. Kidney360, 2021,2(7): 1115-1123.
[33] NORDYKE R J, NICHOLSON G, GAGE S M, et al. Vascular access-specific health-related quality of life impacts among hemodialysis patients: qualitative development of the hemodialysis access-related quality of life (HARQ) instrument[J]. BMC Nephrol, 2020,21(1): 16.
[34] 高希娟. 基于渥太华决策支持框架的血液透析患者血管通路决策辅助工具的构建研究[D]. 山东大学, 2024.
[35] 李梦奇, 孙蓓, 汪洋, 等. 日间化学治疗模式下医护人员对静脉治疗护士主导的血管通路共享决策认知与体验的质性研究[J]. 华西医学, 2024,39(02): 234-239.
[36] DIOUF N T, MENEAR M, ROBITAILLE H, et al. Training health professionals in shared decision making: Update of an international environmental scan[J]. Patient Educ Couns, 2016,99(11): 1753-1758.
[37] van DULMEN S, PEEREBOOM E, SCHULZE L, et al. The use of implicit persuasion in decision-making about treatment for end-stage kidney disease[J]. Perit Dial Int, 2022,42(4): 377-386.
[38] BERNACKI R E, BLOCK S D. Communication about serious illness care goals: a review and synthesis of best practices[J]. JAMA Intern Med, 2014,174(12): 1994-2003.
[39] 陈柳因, 胡元川, 傅麒宁, 等. 维持性血液透析患者对血透通路相关知识的知晓情况调查[J]. 重庆医学, 2020,49(21): 3656-3659.
[40] KANBAY M, BASILE C, BATTAGLIA Y, et al. Shared decision making in elderly patients with kidney failure[J]. Nephrol Dial Transplant, 2024,39(5): 742-751.
[41] 张金娜, 朱秀丽, 张业玲. 早期非小细胞肺癌患者参与手术决策现状调查及影响因素[J]. 齐鲁护理杂志, 2020,26(06): 32-36.
[42] UBBINK D T, MATTHIJSSEN M, LEMRINI S, et al. Systematic review of barriers, facilitators, and tools to promote shared decision making in the emergency department[J]. Acad Emerg Med, 2024,31(10): 1037-1049.
[43] LYNCH J R W H A N. Achieving the goal of the fistula first breakthrough initiative for prevalent maintenance hemodialysis patients[J]. American Journal of Kidney Diseases, 2011,57: 78-89.
[44] KLIGER A S. Quality Measures for Dialysis: Time for a Balanced Scorecard[J]. Clin J Am Soc Nephrol, 2016,11(2): 363-368.
[45] DOROUGH A, FORFANG D, MURPHY S L, et al. Development of a person-centered interdisciplinary plan-of-care program for dialysis[J]. Nephrol Dial Transplant, 2020,35(8): 1426-1435.
[46] CREWS D C, BELLO A K, SAADI G. Burden, Access, and Disparities in Kidney Disease[J]. Kidney Dis (Basel), 2019,5(2): 126-133.
[47] 张晓雅, 苗金红, 王瑞敏, 等. 血液净化中心血管通路护士岗位设置效果分析[J]. 中国血液净化, 2020,19(09): 637-640.
[48] VIECELLI A K, TONG A, O'LONE E, et al. Report of the Standardized Outcomes in Nephrology-Hemodialysis (SONG-HD) Consensus Workshop on Establishing a Core Outcome Measure for Hemodialysis Vascular Access[J]. Am J Kidney Dis, 2018,71(5): 690-700.
[49] URQUHART-SECORD R, CRAIG J C, HEMMELGARN B, et al. Patient and Caregiver Priorities for Outcomes in Hemodialysis: An International Nominal Group Technique Study[J]. Am J Kidney Dis, 2016,68(3): 444-454.
[50] 王萌, 魏丽敏, 刘华, 等. 医护患一体化联合“策划-实施-检查-措施”管理模式改善维持性血液透析患者低钙血症[J]. 中国血液净化, 2019,18(12): 861-864.
[51] STACEY D, LEWIS K B, SMITH M, et al. Decision aids for people facing health treatment or screening decisions[J]. Cochrane Database Syst Rev, 2024,1(1): CD1431.
[52] NICE. shared decision-making guidelines [EB/OL]. [2025-07-20]. https://www.nice.org.uk/guidance/ng197.